The iShares U.S. Pharmaceuticals ETF (NYSEArca: IHE) and the Market Vectors Pharmaceutical ETF (NYSEArca: PPH) rose 3.3% and 2.5%, respectively, last week, but saw no inflows or outflows. [Ackman Would Like These Pharma ETFs]
A portfolio manager quoted by Bloomberg “said medical-device companies and some drug companies are good areas for investment, and the industry consolidation means higher earnings potential for big-name pharmaceuticals.”
The iShares U.S. Medical Devices ETF (NYSEArca: IHI) is up 3% this year and has brought in $245.7, or 34.5%, of its current assets under management tally since the start of 2014. [Medical Device ETF Soars]
iShares U.S. Medical Devices ETF
